Clinical uses of brain natriuretic peptide in diagnosing and managing heart failure

Journal of the American Academy of Nurse Practitioners

Volumn 20, Issue 6, 2008, Pages 305-310

  Anderson, Kelley M ^a,b,c,d,e  

^a Cardiovascular Group   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c CATHOLIC UNIVERSITY OF AMERICA   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

^e NONE   (United States)

Author keywords

Brain natriuretic peptide (BNP); Heart failure; Pathophysiology

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; DIAGNOSTIC AGENT;

HEART FAILURE; HUMAN; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; RISK FACTOR;

BIOLOGICAL MARKERS; HEART FAILURE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; RISK FACTORS;

EID: 45249101777     PISSN: 10412972     EISSN: 17457599     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2008.00327.x     Document Type: Review

References (18)

1. Adlam, D., Silcocks, P. Sparrow, N. (2005). Using BNP to develop a risk score for heart failure in primary care. European Heart Journal, 26, 1086 1093.
2. American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2005). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult - Summary article. Journal of the American College of Cardiology, 46, 1116 1143.
3. Bettencourt, P., Azevedo, A., Pimenta, J., Frioes, F., Ferreira, S. Ferreira, A. (2004). N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation, 110, 2168 2174.
4. Bruins, S., Fokkema, M. R., Romer, J. W. P., DeJongste, M. J. L., van der Dijs, F. P. L., Van den Ouweland, J. M. W., et al 2004). High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clinical Chemistry, 50, 2052 2058.
5. Cheng, V., Kazanagra, R., Garcia, A., Lenert, L., Krishnaswamy, P., Gardetto, N., et al 2001). A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: A pilot study. Journal of the American College of Cardiology, 37, 386 391.
6. Cowie, M. R., Struthers, A. D., Wood, D. A., Coats, A. J. S., Thompson, S. G., Poole-Wilson, P. A., et al 1997). Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet, 350, 1349 1353.
7. Dao, Q., Krishnaswamy, P., Kazanegra, R., Harrison, A., Amirnovin, R., Lenert, L., et al 2001). Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. Journal of the American College of Cardiology, 37, 379 385.
8. Doust, J. A., Glasziou, P. P., Pietrzak, E. Dobson, A. J. (2004). A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Archives of Internal Medicine, 164, 1978 1984.
9. Doust, J. A., Pietrzak, E., Dobson, A. Glasziou, P. P. (2005). How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: Systematic review. British Medical Journal, 330, 625 633.
10. Heart Failure Society of America 2006). HFSA 2006 comprehensive heart failure practice guideline. Journal of Cardiac Failure, 12, 10 38, e1 e122. Retrieved March 1, 2006, from http://www.hfsa.org
11. James, K. B., Troughton, R. W., Feldschuh, J., Soltis, D., Thomas, D. Fouad-Tarazi, F. (2005). Blood volume and brain natriuretic peptide in congestive heart failure: A pilot study. American Heart Journal, 150, 984.e1 984.e6.
12. McCullough, P. A., Nowak, R. M., McCord, J., Hollander, J. E., Hermann, H. C., Steg, P. G., et al 2002). B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure. Circulation, 106, 416 422.
13. Morrow, D. A., deLemons, J. A., Blazing, M. A., Sabatine, M. S., Murphy, S. A., Jarolim, P., et al 2005). Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. Journal of the American Medical Association, 294, 2866 2871.
14. Phua, J., Lim, T. K. Lee, K. H. (2005). B-type natriuretic peptide: Issues for the intensivist and pulmonologist. Critical Care Medicine, 33, 2094 2103.
15. Prahash, A. Lynch, T. (2004). B-type natriuretic peptide: A diagnostic, prognostic and therapeutic tool in heart failure. American Journal of Critical Care, 13, 46 55.
16. Shah, M. R., Claise, K. A., Bowers, M. T., Bhapkar, M., Little, J., Nohria, A., et al 2005). Testing new targets of therapy in advanced heart failure: The design and rationale of the strategies for tailoring advanced heart failure regimens in the outpatient setting: Brain natriuretic peptide versus the clinical congestion score (STARBRITE) trial. American Heart Journal, 150, 893 898.
17. Wang, C. S., Fitzgerald, J. M., Schulzer, M., Mak, E. Ayas, N. T. (2005). Does this dyspneic patient in the emergency department have congestive heart failure? Journal of the American Medical Association, 294, 1944 1956.
18. Zile, M. R., Baicu, C. F. Bonnema, D. D. (2005). Diastolic heart failure: Definitions and terminology. Progress in Cardiovascular Diseases, 47, 307 313.